Cause of death, by non-communicable diseases, ages 5-14, male in Norway
Norway: Cause of death, by non-communicable diseases, ages 5-14, male was 69.1% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, male in Norway, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 5-14.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 5-14, male in Norway is 69.1%, measured in 2021.
Compared with earlier readings it is up 6.1% on the previous year and up 14.9% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, male in Norway peaked at 71.4% in 2019 and was at its lowest, 47.4%, in 2000.
Norway ranks 13th of 185 countries on this measure, in the top 10%.
Cause of death, by non-communicable diseases, ages 5-14, male in Norway, year by year
| Year | % of total male deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 47.4% | — |
| 2010 | 60.1% | +26.8% |
| 2015 | 63.4% | +5.5% |
| 2019 | 71.4% | +12.5% |
| 2020 | 65.1% | -8.7% |
| 2021 | 69.1% | +6.1% |
Norway compared with similar countries
- Norway's 69.1% is above the median for high income countries, which is 57.8%, 1.2× the median. (58 countries reporting)
- Norway's 69.1% is above the median for Europe & Central Asia, which is 54.5%, 1.3× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 47.4% | 47.4% | 47.4% | 1 |
| 2010s | 65.0% | 60.1% | 71.4% | 3 |
| 2020s | 67.1% | 65.1% | 69.1% | 2 |
Countries ranked near Norway
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,212 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate -0.217 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0238 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0617 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, male in Norway?
- Cause of death, by non-communicable diseases, ages 5-14, male in Norway was 69.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, male recorded in Norway?
- The highest recorded value was 71.4% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, male recorded in Norway?
- The lowest recorded value was 47.4% in 2000.
- How does Norway rank for cause of death, by non-communicable diseases, ages 5-14, male?
- Norway ranks 13th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, male rising or falling in Norway?
- Over the last ten years it is up 14.9%. The long-run trend across the full record is rising.
- Where does this Norway data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.